Ursprung des Netzwerks ersten Grades von Melissa Israel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
28
| Public Company | Biotechnology | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Melissa Israel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Graduate Degree Masters Business Admin | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| CARMAT | Medical Specialties | Founder Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| Philipps University of Marburg | College/University | Doctorate Degree Doctorate Degree | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
American Chamber of Commerce In Denmark
 American Chamber of Commerce In Denmark Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Denmark is an organization that provides news, events, membership forums, and resources related to business in Denmark. The American Chamber of Commerce in Denmark is based in Copenhagen, Denmark. The organization focuses on promoting transatlantic data flows and foreign direct investments. Recently, the Danish government announced that it will invest 143 billion kroner in defense over the next decade. The organization also holds more than 50 events a year, including seminars and workshops on topics such as workforce planning and Danish taxation for expats. | Miscellaneous Commercial Services | Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Vital Sensors Holding Co., Inc.
 Vital Sensors Holding Co., Inc. Electronic Equipment/InstrumentsElectronic Technology Vital Sensors Holding Co., Inc. Develops chip based pressure sensors. It offers continuous or on demand data capture and read out capabilities that will support clinicians and patients in the management of cardiovascular and other disease state. The company was founded in 2002 by Volker Bödecker and Max Georg Ostermeier and is headquartered in Richmond, VA. | Electronic Equipment/Instruments | Chief Operating Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Shango SA
 Shango SA Miscellaneous Commercial ServicesCommercial Services Shango SA is a Belgian company that provides business and management advisory services. The private company is based in Elsene, Belgium. The company was founded in 2013. | Miscellaneous Commercial Services | Director/Board Member | |
Zodiac International SAS
 Zodiac International SAS Recreational ProductsConsumer Durables Zodiac International SASU provides boat building and repairing services. The company was founded in 1972 and is headquartered in Paris, France. | Recreational Products | Chairman | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Serono Genetics Institute SA
 Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
MTS Health Partners LP
 MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman | |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Babalia SA
 Babalia SA Financial ConglomeratesFinance Babalia SA provides investment services. | Financial Conglomerates | Chairman | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
Nepteam
 Nepteam Investment ManagersFinance Nepteam provides investment fund and financial services. | Investment Managers | Director/Board Member | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman | |
| Downtown Community Television Center | Director/Board Member | ||
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| COMPASS PATHWAYS PLC | Biotechnology | Director of Finance/CFO | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Marseille | College/University | Doctorate Degree | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bioxodes SA
 Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Chairman | |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Chairman |
Statistik
International
| Frankreich | 16 |
| Vereinigte Staaten | 16 |
| Vereinigtes Königreich | 8 |
| Belgien | 7 |
| Dänemark | 4 |
Sektoral
| Health Technology | 24 |
| Commercial Services | 10 |
| Consumer Services | 9 |
| Finance | 6 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 136 |
| Chairman | 69 |
| Chief Executive Officer | 50 |
| Corporate Officer/Principal | 41 |
| Founder | 38 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Hugo Brugière | 33 |
| Pierre Bastid | 29 |
| Michel de Rosen | 28 |
| Lawrence Steinman | 26 |
| James Kuo | 24 |
| David Solomon | 22 |
| Piers John Morgan | 18 |
| Lena Elisabeth Svanberg | 16 |
| Joshua Schafer | 10 |
| Burkhard Blank | 10 |
| Jean Combalbert | 8 |
| Robert Quinn | 7 |
| Peter Collum | 7 |
| Adrian Hepner | 7 |
- Börse
- Insiders
- Melissa Israel
- Unternehmensverbindungen
